Most Cancer Drugs Granted Accelerated Approval Fail Confirmatory Trials

(MedPage Today) -- SAN DIEGO -- Most cancer drugs granted accelerated approval by the FDA have not demonstrated a benefit in overall survival (OS) or quality of life within 5 years, according to a cohort study presented here. Of 46 cancer drug...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news